Members of the Senate Commerce Committee heard testimony yesterday from panelists mostly in favor of a recently reintroduced bill that would compel pharmacy benefit managers (PBM) to be transparent about their pricing practices and to get them to stop unfair or deceptive conduct that drives up costs for consumers.
Source: Drug Industry Daily